All Pharma News
price-trendAsk Us
Roche doubles down on promising inflammation field with Inflazome buy

Roche doubles down on promising inflammation field with Inflazome buy
D.W. House SEEKING ALPHA
25 Sep 2020
Share Share
Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position

Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position
N. P. Taylor FIERCE BIOTECH
22 Sep 2020
Share Share
Inflazome Announces Its Acquisition By Roche

Inflazome Announces Its Acquisition By Roche
BUSINESSWIRE
21 Sep 2020
Share Share
FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for (CAPS)

FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for (CAPS)
BUSINESSLWIRE
14 Jul 2020
Share Share
FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment

FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment
BUSINESSWIRE
14 Jul 2020
Share Share
Inzomelid completes Ph I studies and shows +ve results treatment of Cryopyrin

Inzomelid completes Ph I studies and shows +ve results treatment of Cryopyrin
BUSINESSWIRE
26 Mar 2020
Share Share